PeptideStack
5.2kquestions
20kanswers
220users

What should a certificate of analysis contain to be worth reading?

Asked 29 Aug 2024Modified 20 months agoViewed 14k times
20

The lot number on the vial matches the certificate, which at least rules out the easy problem.

I have done this once and I suspect I got away with it rather than got it right.

For context: I keep records of every batch, every lot number and every result, so an answer that requires me to track something is fine.

What would you do, and what would you check afterwards?

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

436 questions
residual-solvent
residual-solvent

Solvents left behind by synthesis and purification - acetonitrile, TFA, DMF, DCM - their ICH limits, how they are measured by headspace GC, and…

14 questions
shareeditfollowflag
LW
askedlinnea_wahlberg14k1829 Aug 2024

3 Answers

Accepted answer first, then by votes
156

Accepted answer

Start from what the certificate claims to measure and what the claimed measurement actually answers, because those are two different questions.

The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.

Reconciling gross mass to label claim

ComponentTypical shareCounted in purity?Counted in content?
Target peptide88–94 %Yes, as main peakYes
Related impurities1–3 %Yes, as other peaksNo
Counter-ion (TFA or acetate)2–8 %NoNo
Residual water2–6 %NoNo
Bulking agent, if present0–40 %NoNo

Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.

Industry guidance on this topic is consistent because it comes from first principles rather than convention.

Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.

If the certificate does not trace to your vial, it is not evidence about your vial.

edited 17 Nov 2024 by coring_risk — added a caveat about sampling

shareimprove this answerflag
CR
answered · acceptedcoring_risk17k1827 Oct 2024
8This is the first explanation of that which has actually made sense to me. – cal_hennessy 7 months ago
7Note that the label instructions differ between agents on precisely this point. – Dr_Bram_Verhoeven 5 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
61

Reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.

Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.

To be exact about it, lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.

The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.

The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

edited 17 Nov 2024 by Dr_Jonas_Halvorsen — corrected a unit error in the worked example

shareimprove this answerflag
DH
answeredDr_Jonas_Halvorsen41k387 Nov 2024
3Minor: the trial name is hyphenated in the original publication. – assay_blank 4 months ago
add a comment
45

What a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.

A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.

Concretely, the test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.

Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.

One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.

My working rule is that a document without a lot number, a method section and a test date is marketing.

shareimprove this answerflag
DF
answeredDr_Colm_Fitzhenry85k2485 Oct 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.